Cian Healthcare (BOM:542678) EBIT : ₹58.4 Mil (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cian Healthcare EBIT?

Cian Healthcare's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2024 was ₹38.4 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹58.4 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Cian Healthcare's annualized ROC % for the quarter that ended in Mar. 2024 was 8.62%. Cian Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 9.08%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Cian Healthcare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 5.04%.

Cian Healthcare EBIT Historical Data

The historical data trend for Cian Healthcare's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cian Healthcare EBIT Chart

Cian Healthcare Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT

Get a 7-Day Free Trial

35.89

82.31

1.61

76.80

58.42

Cian Healthcare Semi-Annual Data
	Mar16	Mar17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
EBIT	Get a 7-Day Free Trial										-15.02	33.08	43.72	20.00	38.41

Competitive Comparison of Cian Healthcare's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Cian Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cian Healthcare's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cian Healthcare's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cian Healthcare's EV-to-EBIT falls into.

Cian Healthcare EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹58.4 Mil.

Cian Healthcare (BOM:542678) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Cian Healthcare's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	73.004 * ( 1 - -53.38% )	/	( (1310.993	+	1287.107)	/ 2 )
=	111.9735352	/	1299.05
=	8.62 %

where

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1631.171	-	311.576	-	( 8.602	-	max(0, 705.834	-	787.42	+	8.602	))
=	1310.993

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1611.757	-	312.709	-	( 11.941	-	max(0, 661.116	-	717.426	+	11.941	))
=	1287.107

Note: The Operating Income data used here is two times the semi-annual (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Cian Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	76.828	/	( ( (562.638 + max(319.899, 0))	+	(539.831 + max(270.527, 0)) )	/	2 )
=	76.828	/	( ( 882.537	+	810.358 )	/	2 )
=	76.828	/	846.4475
=	9.08 %

where Working Capital is:

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(282.695	+	391.012	+	51.582)	-	(311.576	+	0	+	93.814)
=	319.899

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(204.827	+	409.272	+	35.593)	-	(312.709	+	0	+	66.456)
=	270.527

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Cian Healthcare's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	58.417	/	1158.618
	=	5.04 %

Cian Healthcare EBIT Related Terms

Thank you for viewing the detailed overview of Cian Healthcare's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Cian Healthcare (BOM:542678) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cian Healthcare Ltd (BOM:542678) » Definitions » EBIT

Traded in Other Exchanges

N/A

Address

Vitthal Rao Shivarkar Road, Office No. 508-511, 5th Floor, Sacred World, Above Macdonald, Wanowrie, Pune, MH, IND, 411040

Website

https://www.cian.co

Cian Healthcare Ltd is a fully integrated pharmaceutical company. It is engaged in the research, development, and manufacturing of different forms of tablets, capsules, soft gels, liquid orals, ointments/ creams & sachets. The company's portfolio comprises of gynecology, hematinic, cardio-diabetic, orthopedic, pediatric, derma-cosmetic, antibiotics, CNS, vitamins, and nutrient products. It operates in five sectors namely Export, Government Supplies, Merchant Export, Own Brand Franchise Business, and Third Party. The majority of the revenue is generated from the Indian Market.

Cian Healthcare (BOM:542678) Headlines

No Headlines